Mangoceuticals, Inc. (MGRX) Institutional Ownership

Ownership Summary

The institutional landscape for Mangoceuticals, Inc. (NASDAQ:MGRX) includes 15 filers as of the latest reporting cycle ending December 2025.

• The collective stake of institutional investors in Mangoceuticals moved to 41.6% in December 2025, a shift up from the 6.1% reported for September 2025.
• The company experienced a 599.38% quarterly change in institutional shares held, alongside an increase of 50.00% in total owners annually.
• Among the 15 institutional holders of Mangoceuticals, 12 added to their stakes while 1 trimmed their positions and 2 held steady.
• This class of investors increased its holdings in Mangoceuticals to 2.35Mn shares for the 13F-cycle ending December 2025, up by 2.02Mn shares quarter on quarter, and up 2.26Mn shares year over year.
• The top institutional stake in Mangoceuticals as of December 31, 2025 belongs to ARMISTICE CAPITAL, LLC, which owns 1.54Mn shares, or 27.18% of the company.
• Among the most significant buyers of Mangoceuticals during December 2025 were ARMISTICE CAPITAL, LLC (1.54Mn), VANGUARD GROUP INC (297.53K), JANE STREET GROUP, LLC (47.50K), UBS Group AG (46.16K), BOOTHBAY FUND MANAGEMENT, LLC (38.44K).
• Leading sellers of Mangoceuticals stock in December 2025 included BANK OF AMERICA CORP /DE/ (69).
• The top 10 institutional holders of Mangoceuticals for the quarter ending December 2025 included ARMISTICE CAPITAL, LLC (1.54Mn), VANGUARD GROUP INC (489.53K), GEODE CAPITAL MANAGEMENT, LLC (108.32K), JANE STREET GROUP, LLC (47.50K), UBS Group AG (46.17K), BOOTHBAY FUND MANAGEMENT, LLC (38.44K), NORTHERN TRUST CORP (37.58K), Ackerman Capital Advisors, LLC (34.50K), Csenge Advisory Group (10.00K), OSAIC HOLDINGS, INC. (2.88K).